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The advent of RNA interference (RNAi) technology has truly revo-
lutionized modern biology. The ability to scrutinize biological
function by knocking out virtually any gene using small interfering
(si)RNAs now allows genetic studies to be completed at a genome-
wide level. As such, RNAi in combination with transcriptional pro-
filing and other molecular technologies provides a powerful tool to
unravel the complex interactions that mediate environmental
pathogenesis.
Transcriptional profiling has been used successfully to study
mechanisms of cellular injury in response to toxic chemicals, iden-
tify molecular targets for environmental exposure, and elucidate
biological pathways underlying the pathogenesis of environmental
disease. Consequently, DNA microarrays are now a mainstay in
the elucidation of molecular signatures of the response triggered by
foods and biological and chemical agents encountered in the envi-
ronment. Changes in mRNA profiles follow chemical binding and
activation/inactivation of transcription factors, as seen with hor-
mone receptors or aryl hydrocarbon receptor (AhR), or modifica-
tions of macromolecules and organelles that disrupt cellular
homeostasis. Once a pattern of gene expression is identified and
associated with a biological phenomenon, the central issue becomes
the validation of putative associations.
Such analyses have greatly benefited from the application of
mathematical and computational approaches to translate the com-
plex biological interactions into units that can be resolved with
greater ease. However, even when the functional interactions of
thousands of genes are minimized to hundreds of genes within criti-
cal nodes of biological activity, the reciprocal, synergistic, collateral,
dependent, or antagonistic interactions that mediate a given biologi-
cal response cannot be ascertained. Classic gene knockout experi-
ments involving deletion or mutational inactivation of target genes
can be used successively to address such questions of certainty.
However, this technology is costly and time consuming and is
of limited value if embryonic viability, developmental program-
ming, and/or reproducibility are compromised. Because conven-
tional knockout methodology often involves a single gene, the
approach is clearly not suitable for high-throughput analysis of gene
functions. Consequently, one major goal in functional genomics has
been the development of tools that allow easy manipulation of gene
expression levels in cell culture, tissue, and whole animal and that
would be suitable for high-throughput analysis. RNAi has emerged
as one of the preferred approaches to achieve this goal.
RNAi is an important biological mechanism in the regulation
of gene expression in plants, fungi, and animals [for review see
Dykxhoorn et al. (2003)]. While the ribosomal and transfer RNAs
participate in protein synthesis on ribosomes, a new class of func-
tional RNAs can prevent protein synthesis through interference
with translating mRNAs. RNAi, also referred to as posttranscrip-
tional gene silencing (PTGS), selectively ablates the effect of a gene
by destroying messenger (m)RNA. RNA regulatory molecules
either reduce or eliminate target gene expression by binding
mRNA and targeting it for degradation by cellular enzymes.
Genetic and biochemical data indicate that siRNAs [19- to 25-
nucleotide double-stranded (ds)RNAs] are produced from much
larger RNAs by Dicer. Upon binding through base-pairing to tar-
get mRNA, siRNAs recruit RNases to a protein complex called the
RNA-induced silenc-
ing complex (RISC)
that degrades the tar-
geted sequence.
RNAi is critical in
viral defense and
transposon silencing (Sijen and Plasterk 2003; Voinnet 2001), het-
erochromatin formation in Schizosaccharomyces (Volpe et al. 2002),
RNA-dependent DNA and histone methylation in plants (Matzke
et al. 2001; Zilberman et al. 2003), and programmed DNA dele-
tion in Tetrahymena (Yao et al. 2003). While it remains unclear
whether endogenous RNAi mechanisms operate in mammalian
cells as described in other organisms, a recent study shows that loss
of Dicer in mice leads to lethality early in development due to
depletion of stem cells (Bernstein et al. 2003). This observation
suggests that Dicer, a conserved component of the RNAi machin-
ery, is required for vertebrate development. Previous studies in
plants and worms have also pointed to a developmental role for the
RNAi machinery (Hannon 2002).
The nematode Caenorhabditis elegans is the first organism in
which dsRNA was used to silence RNA (Fire et al. 1998). Because
of the availability of a complete genomic sequence and the ease of
genetic manipulation (simply soaking the worm in a solution con-
taining dsRNA or by feeding the worm with bacteria expressing
specific dsRNA), large-scale functional analysis of C. elegans genes
has been performed in the whole animal. Recently, Kamath et al.
(2003) presented the results of an investigation of more than
16,000 genes for loss-of-function phenotypes in C. elegans. This is
the first study of its kind and could provide insights into human
gene function, given that more than half the genes in C. elegans are
homologous to human genes. Most studies to date indicate that
RNAi occurs in the cytoplasm by acting on translating polyribo-
somes. However, recent studies have shown that in the yeast
Schizosaccharomyces pombe, silencing of centromeric repeats is
mediated by dsRNA and Dicer/RISC (Volpe et al. 2002). Another
study in trypanosomes directly demonstrates that siRNAs can
attack small nucleolar (sno)RNAs, non-mRNAs involved in the
biosynthesis of ribosomal RNA in the nucleolus (Liang et al.
2003). 
The availability of searchable genetic databases such as BLAST
has greatly accelerated progress in the field of functional genomics.
Of great potential impact to the field is the availability of the first
RNAi database, RNAiDB, for archiving, distribution, and analyses
of phenotypic data derived from large-scale RNAi experiments in
C. elegans (Gunsalus et al. 2004). RNAiDB can be searched using
combinatorial queries and the novel tool PhenoBlast, which ranks
genes according to their overall phenotypic similarity. Thus,
RNAiDB could serve as a model database for distributing and nav-
igating in vivo functional information from large-scale systematic
phenotypic analyses in different organisms. 
RNAi has also emerged as a powerful genetic tool for analy-
ses of gene function in mammalian cells [reviewed by
Dykxhoorn et al. (2003)]. Cell culture–based assays of gene
function are already conducted in a 96- or 384-well plate for-
mat. For example, a recent investigation based on silencing of
510 genes identified new cellular components that modulate the
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inducing ligand (TRAIL) (Aza-Blanc et al. 2003). Moreover,
recent studies have used microarray-based cell transfection plat-
forms to achieve large-scale measurable RNAi-induced knock-
downs and phenotypes in mammalian cells (Kumar et al. 2003;
Mousses et al. 2003). In these experiments, siRNAs are first
arrayed on glass slides, overlaid with a monolayer of cells, and
incubated to allow transfection to occur. A fluorescent end point
is then used as a quantitative measure of RNAi. A significant
advantage of this platform when compared to a plate format is
the uniformity of experimental design and conditions that allow
for all processes to take place on the same surface. Potentially,
any assay that can be conducted using cells growing on a glass
slide can be applied to the RNAi microarray platform. This
should enable analysis of phenotypic end points such as toxicity,
differentiation, and cell cycle effects to directly evaluate gene
function.
Although RNAi experiments rely on high target specificity,
nonspecific effects can and do occur. Recent reports demon-
strate that under certain conditions mammalian cells treated
with 21-bp siRNAs may also activate components of the inter-
feron system (Jackson et al. 2003; Persengiev et al. 2004; Sledz
et al. 2003). This suggests that when introduced into cells,
siRNAs have broad and complex effects beyond the selective
silencing of target genes. Therefore, investigators must proceed
with caution when interpretating data using RNAi technology. 
Clearly, the application of RNAi to environmental health
research will help address critical questions at a genome-wide
level. A recent study demonstrated that downregulation of AhR by
siRNA inhibits functional interactions between dioxin and estro-
gen, and modulates transition of MCF-7 breast cancer cells
through the cell cycle (Abdelrahim et al. 2003). These findings not
only ratified the critical role of AhR in the regulation of mam-
malian functions but also lend credence to the usefulness of siRNA
methodology in evaluating the mammalian response to environ-
mental injury. Allele-specific silencing of acetylcholine receptor
subunit mutants has also being recently reported (Abdelgany et al.
2003), suggesting that this approach may find applications in the
study of dominant genetic disorders associated with environmental
exposures. Finally, siRNAs are now being used to facilitate target
selection at various stages of drug development (Lavery and King
2003). We are currently applying RNAi technology to the study of
four-gene interaction networks involved in the regulation of AhR-
dependent functions and phenotypic control of mammalian cells.
Clearly, the door to RNAi has just opened for environmental
health researchers. The best is yet to come.
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“One of the major goals in functional genomics has been the development of tools that allow easy manipulation
of gene expression levels in cell culture, tissue and whole animal and that would be suitable for high-throughput
analysis.  RNAi has emerged as one of the preferred approaches to achieve this goal. . . .  The application of
RNAi to environmental health research will help address critical questions at a genome-wide level.”